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Rochester, MinnesotaSUMMARY Gating of the muscle-type acetylcholine receptor (AChR) channel depends on communication between the ACh-
binding site and the remote ion channel. A key region for this communication is located within the structural transition zone
between the ligand-binding and pore domains. Here, stemming from b-strand 10 of the binding domain, the invariant
aArg209 lodges within the hydrophobic interior of the subunit and is essential for rapid and efficient channel gating. Previous
charge-reversal experiments showed that the contribution of aArg209 to channel gating depends strongly on aGlu45, also within
this region. Here we determine whether the contribution of aArg209 to channel gating depends on additional anionic or electron-
rich residues in this region. Also, to reconcile diverging findings in the literature, we compare the dependence of aArg209 on
aGlu45 in AChRs from different species, and compare the full agonist ACh with the weak agonist choline. Our findings reveal
that the contribution of aArg209 to channel gating depends on additional nearby electron-rich residues, consistent with both elec-
trostatic and steric contributions. Furthermore, aArg209 and aGlu45 show a strong interdependence in both human and mouse
AChRs, whereas the functional consequences of the mutation aE45R depend on the agonist. The emerging picture shows
a multifaceted network of interdependent residues that are required for communication between the ligand-binding and pore
domains.INTRODUCTIONAt the vertebrate motor synapse, nerve-released acetylcho-
line (ACh) binds to and opens postsynaptic ACh receptor
(AChR) channels in the final step of synaptic transmission.
The sites to which ACh bind are readily accessible from the
synaptic cleft, but the channel gate lies deep within the
membrane, remote from the binding sites. An enduring
quest is to identify substructures within the AChR that
communicate structural changes from the ACh binding
site to the channel gate.
Within the AChR pentamer, the two ACh-binding sites
are formed at interfaces between each of two a-subunits
and either the ε- or d-subunit (1,2). Structure determination
and molecular-dynamics simulations showed that when the
agonist binds, the sites contract around and envelop the
agonist (3–7). In particular, loop C from the a-subunit
changes from an opened-up to a closed-in conformation.
When loop C closes in upon the agonist, a key interaction
is established between aTyr190 from the first half of loop
C and aLys145 of b-strand 7, and a second interaction
between aAsp200 from the second half of loop C and
aLys145 is maintained in both conformations. Mutagenesis
studies showed that both interactions are required to couple
agonist binding to channel gating efficiently, and thus they
contribute to early steps in signal transduction (8). In sup-
port of these findings, rate-equilibrium, free-energy anal-
yses applied to residues at the agonist-binding site showed
that the free energy of the channel-opening transitionSubmitted July 2, 2012, and accepted for publication December 6, 2012.
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0006-3495/13/01/0355/13 $2.00changed in direct proportion with that of the channel-gating
equilibrium, suggesting that residues at the binding site are
among the first to change their conformation during the tran-
sition from a closed- to open-channel state (9).
b-strands 7, 9, and 10 extend from the ligand-binding site
to the junction with the pore domain, where they give rise to
the Cys loop, b8-b9 loop, and pre-M1 region, respectively.
At this junction, these three structures coalesce with the
b1-b2 loop from the binding domain and the M2-M3 loop
from the pore domain. Within this assembly of interdomain
loops, the invariant aArg209 from b-strand 10 forms a salt
bridge with the conserved aGlu45 from the b1-b2 loop
(Fig. 1). This salt bridge was initially observed in the
cryo-electron microscopy (cryo-EM) structural model of
the Torpedo AChR (10), and subsequently in x-ray struc-
tures of the mouse a1 extracellular domain with bound
a-bungarotoxin (11) and in the pentameric bacterial ion
channel GLIC (12,13). Studies of charge reversal of this
salt bridge showed that it contributed to rapid and effi-
cient coupling of agonist binding to channel gating (14).
Subsequent studies, however, showed that hydrophobic
substitutions for aGlu45 enabled relatively efficient channel
gating (15,16), suggesting that the contribution of aArg209
to channel gating may depend on additional structures in
this region. In support of this possibility, structural data re-
vealed additional negatively charged residues near aArg209
(10,11), suggesting that one or more of these residues could
have compensated for loss of the negative charge following
hydrophobic substitutions for aGlu45.
Herein, we further examine interresidue coupling in the
region between the ligand-binding and pore domains ofhttp://dx.doi.org/10.1016/j.bpj.2012.12.013
ab
FIGURE 1 (a) Structural model of the a-subunit from the TorpedoAChR
(PDB code 2BG9). (b) Close-up view of the region between the ligand-
binding and pore domains. Key residues are highlighted in stick represen-
tation and colored according to electronic charge (blue, positive; red,
negative; and gray, neutral).
356 Mukhtasimova and Sinethe muscle-type AChR, and test whether the contribution of
aArg209 to channel gating depends on additional anionic or
electron-rich residues in this region. To evaluate whether
differences in the AChR species or type of agonist account
for the divergent findings regarding coupling between
aArg209 and aGlu45 (14,16), we compare interresidue
coupling in human and mouse AChRs, and also compare
the full agonist ACh with the weak agonist choline (Ch).
Our findings reveal that aArg209 couples to additional
nearby electron-rich residues in a manner consistent with
both electrostatic and steric contributions, that aArg209
and aGlu45 are strongly coupled in both species of
AChR, and that the functional consequences of the mutation
aE45R depend on the agonist.MATERIALS AND METHODS
Construction of wild-type and mutant AChRs
Human and mouse a, b, d, and ε-subunit complementary DNAs (cDNAs)
were subcloned in the cytomegalovirus-based mammalian expression
vector pRBG4 (17) as previously described (18). Site-directed mutations
were made using the QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA). The presence of each mutation and the absence of unwanted
mutations were confirmed by sequencing the entire cDNA insert.Mammalian cell expression
All experiments were performed using the BOSC 23 cell line (CRL-11270;
ATCC, VA), a variant of the HEK 293 cell line. Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) containing fetal bovine
serum (10% vol/vol) at 37C until they reached ~50–70% confluence.Biophysical Journal 104(2) 355–367Wild-type (WT) or mutant AChR cDNAs, plus the cDNA encoding green
fluorescent protein, were transfected by calcium-phosphate precipitation,
with final concentrations of each cDNA of 0.68 mg/ml. Patch-clamp record-
ings were performed 24–48 h after transfection.Patch-clamp single-channel recordings
To record single-channel currents, cells transfected with WT or mutant
AChR cDNAs were rinsed with and maintained in the following bath solu-
tion (in mM): KCl 142, NaCl 5.4, CaCl2 1.8, MgCl2 1.7, and HEPES 10
(pH was adjusted to 7.4 with NaOH). The same solution was used to fill
patch pipettes. The agonists ACh and Ch (Sigma-Aldrich, St. Louis, MO)
were stored as 100 mM stocks in bath solution at 80C. Glass micropi-
pettes (type 7052; King Precision Glass, Claremont, CA) were coated
with Sylgard 184 (Dow Corning Co., Elizabethtown, KY.) and heat polished
to yield resistances of 5–8 MU. Single-channel currents were recorded in
the cell-attached configuration using the Axopatch 200B (Molecular
Devices LLC, Sunnyvale, CA) at a holding potential of 70 mV in exper-
iments in which ACh was the agonist, and 100 mV in experiments in
which Ch was the agonist (the greater potential used in recordings with
Ch as the agonist was chosen to enable comparison with previous studies
using Ch (16)). The temperature was 22C. Data were collected from two
to four different patches for each agonist concentration. Recordings were
accepted only if channel activity was low enough to allow identification
of activation episodes resulting from a single AChR channel. The current
signal was low-pass filtered at 100 kHz and recorded to hard disk at 500
kHz using the program Acquire (Bruxton, Seattle, WA).Single-channel kinetic analysis
Single-channel kinetic analyses were performed as previously described
(19). Briefly, the digitized current signals were analyzed using a 10-kHz
digital Gaussian filter, interpolated using a cubic spline function, and then
detected using the half-amplitude threshold criterion with correction of
the dwell times at threshold for the effects of the Gaussian filter (20). Given
these parameters, theminimumdetectable open or closed interval was 18 ms.
Open- and closed-time histograms were fitted by the sum of exponentials
by maximum likelihood using the program TACFit (Bruxton). Openings
corresponding to a single receptor channel were identified by assigning
a critical closed time, defined as the point of intersection of the closed-
time component that depended on agonist concentrationwith the succeeding
concentration-independent component (18), presumably due to desensi-
tization. Clusters of events with five or more openings and mean open
probabilities and mean closed times within 2 standard deviations of the
respective means were accepted for further analysis; >90% of clusters
met these criteria. For the aR209Q mutant in human and mouse AChRs,
all openings, except for single isolated openings, were accepted for analysis.
A dead time of 22 ms was imposed on all data sets prior to fitting. Kinetic
fitting according to Scheme 1 (see results) was conducted simultaneously
for data obtained across a range of agonist concentrations (termed global
analysis) using MIL software (Qub suite, State University of New York,
Buffalo, NY), which corrects for missed events, obtains fitted parameters
by maximum likelihood, and gives standard errors (SEs) of the fitted param-
eters (21). For the WT and mutant receptors studied, the global analysis
included data from two to four patches for each agonist concentration
(see Fig. S1, Fig. S2, Fig. S3, Fig .S4, and Fig. S5 in the SupportingMaterial
for agonist concentrations). For the triple mutant aE45RþaE175Lþ
aW176L, kinetic modes were identified as previously described (8).Mutant cycle analysis
To detect interresidue energetic coupling and estimate its magnitude,
we applied mutant cycle analysis (22) to the channel gating equilibrium
constant Q2 computed from the ratio of apparent channel gating rate
Invariant Arginine Couples to Multiple 357constants b2/a2 (19). For each mutant cycle, the interresidue coupling free
energy is given by DDG ¼ -RT lnðQ2;wtQ2;m1 m2=Q2;m1Q2;m2Þ, where R is
the gas constant, T is the absolute temperature, and m1 and m2 are the pair
of mutations. To compute the SE for DDG, the likelihood surfaces for each
fitted b2 or a2 are assumed to be symmetrical about the maximum. The SE
of DDG is then computed from the SE for each rate constant (i.e., SE b2,x)
as follows:
S:E: ¼ RTsqrtvarlogb2;wt
þ varðlogða2;wtÞÞ
þ varlogb2;m1
þ varðlogða2;m1ÞÞ
þ varlogb2;m2
þ varðlogða2;m2ÞÞ
þ varlogb2;m1m2
þ varðlogða2;m1m2ÞÞ

;
where varðlogðb2;xÞÞ  ðs:e:b2;x=b2;xÞ2; varðlogða2;xÞÞ  ðs:e:a2;x=a2;xÞ2.RESULTS
Previous studies examined energetic coupling between
aArg209 and aGlu45 in either the human AChR with
ACh as the agonist (14) or the mouse AChR with a combina-
tion of ACh and the weak agonist Ch (16). The study with
human AChR and ACh indicated a coupling free energy
of 3.1 kcal/mol, whereas the study with mouse AChR
and a combination of ACh and Ch indicated a coupling
free energy of 1.2 kcal/mol. To determine whether differ-
ences in the species of AChR could have accounted for this
divergence, we recorded single-channel currents from both
human and mouse AChRs activated by the same agonist,
ACh. To ensure that the data for the two species were
comparable, we obtained new recordings for the human
WT and mutant AChRs in parallel with those for the mouse
AChR. Single-channel currents were elicited by a range
of ACh concentrations. The minimum concentration was
3 mM because this was the lowest concentration that
produced clearly identifiable clusters of openings from the
same AChR channel, a requirement for kinetic fitting, and
the maximum concentration was 1 mM because higher
concentrations reduced the single-channel current ampli-
tude due to unresolved channel block.
Channel openings and closings, recorded at a bandwidth
of 10 kHz, were detected using the half-amplitude threshold
criterion, and the resulting global set of open and closed
dwell times was analyzed according to the extended del
Castillo and Katz scheme:
ADR%
kD1
k1
ARDA%
kD2
k2
A2R%
b2
a2
A2O%
kDB
kB
A2B
Scheme 1
In Scheme 1, A is ACh, R is the receptor, kþn is the agonist
association rate constant, kn is the agonist dissociation rate
constant, b2 is the channel opening rate constant, a2 is the
channel closing rate constant, and kþb and kb are the
channel blocking and unblocking rate constants, respec-
tively. The rate constants kþ1 and k2 are effective rate
constants, which in the case of equivalent binding sites are
the product of the number of binding sites and the intrin-sic rate constant. To facilitate comparison with previous
analyses (14), and because it could not be defined for
many mutants owing to limited time resolution, we did
not include the recently described brief closed state between
the A2R and A2O states (23,24). Thus, the fitted channel
gating rate and equilibrium constants are apparent rate
and equilibrium constants. The implications of a brief pre-
open closed state are outlined in the Discussion. In the
following sections, the apparent channel gating equilibrium
constant, Q2, given by the ratio b2/a2, is used to compute
coupling free energies between pairs of residues subjected
to mutations.
For WT human and mouse AChRs at a membrane poten-
tial of 70 mV, channel openings elicited by 100 mM ACh
were resolved with a good signal/noise ratio at a bandwidth
of 10 kHz (Fig. 2 a). The corresponding open- and closed-
time histograms are shown along with the fitted probability
density functions (PDFs) from Scheme 1. For human (but
not mouse) AChRs, an improved fit was obtained with the
addition of a singly liganded open state linked to the singly
liganded closed state, AR; addition of this state had little
effect on the fitted rate constants b2 and a2. The fitted
PDFs, generated from simultaneous fitting of all the data
from 3 mM to 1 mMACh, overlay the dwell-time histograms
for both mouse and human AChRs (Fig. 2 a and Fig. S1).
The fitted rate constants are well defined and yield estimates
of Q2, K2, and Kb that are very similar between human
and mouse AChRs (Table 1). Quantitative differences
between the two species include detectable singly liganded
openings in human but not mouse AChRs, and moderate
increases in b2, k1, and k2 in mouse AChRs compared
human AChRs.
For the charge-reversal mutation aE45R, in both human
and mouse AChRs, the single-channel current traces show
briefer channel openings and fewer brief closings, indi-
cating attenuated channel gating. The fitted PDFs from
Scheme 1 superimpose on the closed-and open-time histo-
grams (Fig. 2 a and Fig. S2), and the fitted rate constants
reveal that the aE45R mutation decreases Q2 by 7.5- and
20-fold for the human and mouse AChRs, respectively
(Table 1), in general agreement with the 6.4-fold decrease
previously observed for human AChR activated by ACh
(14). The aE45R mutation also slows the rate constants
for ACh dissociation by >10-fold, decreasing K1 and K2,
indicating the mutation increases agonist affinity. Thus,
in both human and mouse AChRs, substituting Arg for
aGlu45 reduces the channel gating equilibrium constant.
For the mutation aR209Q, the single-channel current
traces show a greater attenuation of channel gating com-
pared with aE45R (Fig. 2 a). The fitted PDFs from Scheme 1
well describe the closed-time histograms from both species,
as well as the open-time histogram for the mouse mutant
AChR (Fig. 2 a and Fig. S3). On the other hand, the open-
time histogram for the human mutant AChR shows a
shortage of events near the peak and an excess of eventsBiophysical Journal 104(2) 355–367
ab
FIGURE 2 (a) Kinetics of activation of human
and mouse AChRs and the indicated mutants.
Currents elicited by 100 mM ACh are shown at
a bandwidth of 10 kHz, with channel openings
shown as upward deflections. Histograms of closed
and open dwell times within identified clusters
are shown on logarithmic time axes with PDFs
generated from global kinetic fitting overlaid (see
Materials and Methods; fitted rate constants are
given in Table 1). (b) Energetic coupling between
aArg209 and aGlu45. In each two-dimensional
mutant cycle, the diagonal line indicates interresi-
due coupling free energy, and the horizontal and
vertical lines indicate free-energy changes due to
mutation. SEs ofDDGwere computed as described
in Materials and Methods. The 95% confidence
limit, or twice the SE, indicates a coupling energy
significantly different from zero.
358 Mukhtasimova and Sinenear the tail, indicating a second doubly liganded open state.
An alternative to Scheme 1, though warranted for human
aR209Q, was not considered because the frame of refer-
ence, the WT AChR, shows a single doubly liganded open
state. Notwithstanding the extended open-time distribution
for human aR209Q, the fitted rate constants show 40–fold
decreases of Q2 for both mutant human and mouse AChRs
(Table 1), which are similar to the decreases previously
observed for mutant human and mouse AChRs activated
by ACh (14,16). Unlike the mutation aE45R, aR209Q has
little effect on the rate constants for ACh dissociation.
Thus, in both human and mouse AChRs, substituting Gln
for aArg209 markedly reduces the channel gating equilib-
rium constant.
Given that aArg209 and aGlu45 are near each other in the
available structures, we combined mutations of both resi-
dues into a single a-subunit to determine whether the func-Biophysical Journal 104(2) 355–367tional consequences of the single mutations change when the
second residue is subjected to mutation. For the double-
mutant human andmouse AChRs, the single-channel current
traces show strikingly enhanced channel gating compared
with either single mutant, approaching that for the corre-
sponding WT AChR (Fig. 2 a). The fitted PDFs from
Scheme 1 conform closely to the closed- and open-dwell-
time histograms for the double-mutant AChRs from both
species (Fig. 2 a and Fig. S4), and the fitted rate constants
confirm that Q2 increases compared with those for the
single-mutant AChRs, approaching Q2 for the correspond-
ing WT AChR (Table 1). Thus, combining the mutations
aR209Q and aE45R increases channel gating efficiency
compared with the single mutant human and mouse AChRs.
These findings indicate that the large decrease in channel
gating caused by the mutation aR209Q depends on
aGlu45, confirming previous observations (14).
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Invariant Arginine Couples to Multiple 359Double-mutant-cycle analysis is a powerful means to
quantify residue interdependence in proteins (22,25). It is
based on the tenet that the change in free energy that
occurs after mutation of a single residue depends on the
surrounding residues. If mutation of a second residue affects
the free-energy change caused by mutation of the first
residue, the two residues will be interdependent and poten-
tially can interact directly; however, evidence for direct
interaction relies on independent structural information.
For the data presented here, we computed the free-energy
change produced by each mutation from estimates of Q2
from kinetic fitting of single-channel dwell times. The
double-mutant cycles for aR209Q and aE45R, shown in
Fig. 2 b, demonstrate large interresidue coupling free ener-
gies of >3 kcal/mol for both the human and mouse AChRs
activated by ACh. These coupling free energies are very
similar to that obtained previously for human AChR acti-
vated by ACh (14), and are much greater than twice the
SE, a convention used to indicate a significant coupling
free energy (22). Thus, aArg209 and aGlu45 show strong
energetic coupling in both human and mouse AChRs.
Because species differences do not account for the diver-
gent estimates of energetic coupling between aArg209 and
aGlu45, we evaluated a second difference in experimental
conditions, the type of agonist, and compared the full
agonist ACh with the partial agonist Ch. We initially exam-
ined the functional consequences of the aE45R mutation
with Ch because this combination of mutation and agonist
showed enhanced rather than diminished channel gating
(16). Channel openings were elicited by a range of Ch
concentrations that produced clearly identifiable clusters
but minimized channel block, and then Scheme 1 was fitted
to each set of global closed and open dwell times. For WT
human and mouse AChRs activated by Ch, channel open-
ings within clusters were very infrequent even at a con-
centration of 6 mM Ch, the highest concentration tested
(Fig. 3). For both species of AChR, the fitted PDFs overlay
the set of global dwell time histograms (Fig. 3, Fig. S5, and
Fig. S6), yielding channel gating equilibrium constants of
0.07 (Table 2), in good agreement with previous estimates
(16,26). By contrast, in both human and mouse AChRs,
the aE45R mutant activated by Ch shows a much greater
frequency of openings within clusters compared with the
WTAChR (Fig. 3). In addition, individual channel openings
are briefer. For aE45R AChRs from both species, the fitted
PDFs closely overlay the global set of dwell-time histo-
grams (Fig. 3, Fig. S5, and Fig. S6), yielding channel gating
equilibrium constants 3- to 7-fold greater than those for
WTAChRs (Table 2). The increases in channel gating arise
from marked increases in the channel opening rate constant
b2, which are partially countered by increases in the channel
closing rate constant a2. Thus, for ACh and Ch, the aE45R
mutant produces opposite changes in channel gating, indi-
cating that this mutation produces an energy landscape for
gating that differs between the two agonists. Furthermore,Biophysical Journal 104(2) 355–367
FIGURE 3 Kinetics of activation of human and
mouse AChRs and the aE45R mutant. Currents
elicited by 3 mM Ch are shown at a bandwidth
of 10 kHz, with channel openings shown as upward
deflections. Histograms of closed and open dwell
times within identified clusters of events are shown
on logarithmic time axes with PDFs generated
from global kinetic fitting overlaid (see Materials
and Methods; fitted rate constants are given in
Table 2).
360 Mukhtasimova and Sinethe agonist dependence of aE45R suggests that ACh and Ch
produce different structural changes within the ligand-
binding domain that are realized as far away as aGlu45.
The question remains, however, of whether aArg209
and aGlu45 show energetic coupling with Ch as the agonist.
We could not address this question quantitatively because
the mutation aR209Q reduced the frequency of channel
openings so that clusters of openings from the same
AChR channel were not apparent (data not shown). Never-
theless, the marked reduction in channel opening frequency
suggests that aR209Q decreases the efficiency of channel
gating elicited by Ch, although the extent of the decrease
cannot be quantified. On the other hand, we asked whether
the double mutation aE45R/aR209Q counteracted the in-
crease in channel gating produced by aE45R alone. When
tested in both mouse and human AChRs, the double muta-
tion decreased the channel gating equilibrium constant for
Ch compared with aE45R alone (Table 2), and approached
that for the WT AChR. Thus, although energetic coupling
between aArg209 and aGlu45 cannot be quantified with
Ch as the agonist, simultaneous mutation of both residues
restores channel gating to normal.
Previous studies showed that hydrophobic substitutions
for aGlu45 enabled a rapid rate of channel opening accom-
panied by efficient channel gating (15,16). Because aGlu45
and aArg209 are physically associated and functionally
coupled, a potential explanation is that charge neutralization
of aGlu45 is compensated for by another local negative
charge. In the cryo-EM structure of the Torpedo AChR
(10), and in x-ray structures of the a1 extracellular domain
(11) and the prokaryotic channel ELIC (13), a second nega-
tive charge, at a position equivalent to aGlu175 in the b8-b9
loop, is near the Arg equivalent to aArg209 (Fig. 1 b). To
determine whether aGlu175 contributes to channel gating,
we generated the charge-reversal mutation aE175R and
recorded single-channel currents activated by ACh. The
single-channel current traces show brief channel openingsBiophysical Journal 104(2) 355–367with long intervening closings, indicating that aE175R
attenuates channel gating (Fig. 4 a). The fitted PDFs for
Scheme 1 describe the closed- and open-dwell-time distri-
butions, and the fitted rate constants show that b2 decreases
and a2 increases compared with the human WT AChR, re-
sulting in a 67-fold reduction in Q2 (Table 3). Thus,
aGlu175, located near aArg209, is required for rapid and
efficient channel gating, suggesting that the contribution
of aArg209 to channel gating also depends on aGlu175.
To test this possibility, we combined mutations of
aArg209 and aGlu175 into the same AChR and recorded
single-channel currents activated by ACh. Recordings
from the double mutant aR209Q/aE175R show enhanced
channel gating compared with that of either single mutation,
exhibiting brief channel openings flanked by brief closings
(Fig. 4 a). The fitted PDFs describe the closed- and open-
time distributions, and the fitted rate constants indicate
increases in Q2 compared with that obtained for either
single mutant, although it remains 17-fold smaller than the
Q2 obtained for the WT AChR (Table 3). A limitation of
these data is that both b2 and a2 are large and similar in
magnitude, a situation in which both approximate and exact
missed-event correction methods can underestimate the two
rate constants. Nevertheless, the large decrease in channel
gating produced by the mutation aR209Q is partially miti-
gated by the charge reversal of aGlu175.
The findings to this point show that both aGlu45
and aGlu175 contribute to channel gating. To determine
whether aGlu45 and aGlu175 contribute jointly to channel
gating, we substituted Arg for both aGlu45 and aGlu175
and recorded single-channel currents activated by ACh.
For the double charge-reversal mutation aE175R/aE45R,
the single-channel current traces show brief channel open-
ings with long intervening closings (Fig. 4 a) similar to
those observed for the aE175R mutation alone. The fitted
PDFs describe the closed- and open-time distributions,
and the fitted rate constants show that Q2 is reduced by
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Invariant Arginine Couples to Multiple 36167-fold compared with that for the WTAChR (Table 3). For
the double mutant aE175R/aE45R, the change in Q2 is the
same as that for the single mutant aE175R, indicating the
functional consequences of the two mutations are not addi-
tive; thus, aGlu45 and aGlu175 contribute to channel gating
interdependently.
To determine whether the contribution of aArg209 to
channel gating depends on aGlu45 and aGlu175, we gener-
ated the triple mutant aR209Q/aE45R/aE175R. Because
both the aR209Q and aE45R/aE175R mutations markedly
suppress channel gating, a further suppression of gating
would be expected if their contributions were independent.
However the triple-mutant AChR shows strikingly enhanced
channel gating compared with either the single- or double-
mutant AChRs (Fig. 4 a). The fitted rate constants reveal
a Q2 of 4.2, which is 14-fold greater than that of the double
mutant aE45R/aE175R (Table 3). Thus, the contribution of
aArg209 to channel gating depends on both aGlu45 and
aGlu175.
Given our estimates of Q2 for the single-, double-, and
triple-mutant AChRs, we generated several mutant cycles
to quantify interresidue coupling free energies within the
triad aArg209, aGlu45, and aGlu175. For the combination
aR209Q and aE175R, the double-mutant cycle (shown in
the left box in Fig. 4 b) reveals a coupling free energy
of 3 kcal/mol, which is similar to that for the aR209Q/
aE45R mutant cycle (Fig. 2 b). For the cycle in which the
mutation aE45R is present at all four vertices (right box
in Fig. 4 b), aR209Q and aE175R remain strongly coupled,
but the coupling free energy decreases by a third. This
decrease may arise because in the context of aR209Q, the
two positive charges, aE175R and aE45R, are mutually
repulsive. Conversely, for the cycle in which the muta-
tion aE175R is present at all four vertices (center box in
Fig. 4 b), aR209Q and aE45R remain strongly coupled,
as in Fig. 2 b, but the coupling free energy again decreases
by almost a third. Thus, in contributing to channel gating,
both aGlu175 and aGlu45 exhibit strong energetic coupling
with aArg209, and charge reversal of either anionic residue
reduces coupling between the remaining anionic residue and
aArg209.
If the tripartite interaction between aGlu45, aGlu175,
and aArg209 is purely electrostatic, substitution of a hydro-
phobic residue for either anionic residue might be expected
to reduce the channel gating equilibrium constant. However,
substitution of either Leu for aGlu45 or Val for aGlu175
results in long channel openings flanked by brief closings,
indicating that channel gating remains efficient (Fig. 5).
For both the aE45L and aE175V mutations, the fitted
PDFs describe the closed- and open-time histograms, and
the fitted rate constants show a slight slowing of the channel
opening rate constants b2 and little change of the channel
closing rate constants a2, yielding Q2 estimates of 8 and
18, respectively, compared with 20 for the WTAChR (Table
S1). Thus, hydrophobic substitutions for either aGlu45 orBiophysical Journal 104(2) 355–367
ab
FIGURE 4 (a) Kinetics of activation of charge-
reversal mutations in human AChR. Currents eli-
cited by 100 mM ACh are shown at a bandwidth
of 10 kHz, with channel openings shown as upward
deflections. Histograms of closed and open dwell
times within identified clusters of events are shown
on logarithmic time axes with probability density
functions generated from global kinetic fitting
overlaid (see Materials and Methods; fitted rate
constants are given in Table 3). (b) Interresidue
energetic coupling as in Fig. 2 b.
362 Mukhtasimova and SineaGlu175 retain efficient channel gating, suggesting that the
remaining anionic residue may compensate for loss of the
negative charge produced by the substituted hydrophobic
residue.
To test the idea of charge compensation, we substituted
Leu for both aGlu45 and aGlu175 and measured single-
channel currents elicited by ACh. However, the double-
mutant AChR exhibits long channel openings flanked by
brief closings, indicating that channel gating remains effi-
cient (Fig. 5). The fitted PDFs describe the closed- and
open-time histograms, and the fitted rate constants reveal
a slowing of the channel closing rate constant a2 resulting
in an increase of Q2 (Table S1). Thus, substituting Leu
for both aGlu45 and aGlu175 enhances rather than dimin-
ishes channel gating. Loss of the two negative charges
may have been compensated for by the steric bulk of the
substituted Leu residues or yet another nearby anionic
residue, or both.
A third, potentially compensating residue, the conserved
aTrp176, is also near aArg209 (Fig. 1 b). To determine
whether aTrp176 contributes to channel gating, we gener-
ated the mutation aW176L and recorded single-channel
currents elicited by ACh. The resulting single-channel
current traces exhibit long channel openings flanked by
brief closings, indicating that channel gating remains
efficient (Fig. 5). The fitted PDFs describe the closed-
and open-time distributions, and the fitted rate constantsBiophysical Journal 104(2) 355–367show decreases in the channel gating rate constants b2
and a2 that together produce a slight increase of Q2
(Table S1). A second mutation, aW176V, reduces Q2 by
more than half (Table S1), perhaps owing to the smaller
size of Val. However, substituting aTrp176 with Ala
or anionic or polar residues did not yield functional chan-
nels (data not shown). Thus, the functional consequences
of aW176L and aW176V are reminiscent of those of
the hydrophobic mutations aE175V, E45L, and aE45L/
aE175L (Table S1).
To test whether retention of efficient channel gating by
the double mutant aE45L/aE175L is compensated for by
aTrp176, we substituted Leu for all three residues and re-
corded single currents activated by ACh. Recordings from
the triple-mutant AChR showed kinetically heterogeneous
channel openings and closings (Fig. 6 a), suggesting mul-
tiple gating modes, unlike the other mutant AChRs exam-
ined herein. Kinetic heterogeneity was evident as abrupt
switches in the pattern of openings and closings within clus-
ters, and also in the wide range of open probabilities among
clusters that showed no abrupt switches. For the triple-
mutant AChR, channel open probabilities within clusters
were reduced overall and spanned a wide range, in con-
trast to the high open probability and narrow range observed
for the WT AChR (Fig. 6 b). Thus, substituting Leu
for all three electron-rich residues surrounding aArg209
suppresses channel gating and produces inhomogeneous
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Invariant Arginine Couples to Multiple 363kinetics. Therefore, although the triple mutation removes
three electron-rich residues, the steric bulk of the three
substituted Leu residues may partially compensate for
this loss.
To test further for steric contributions of the three electron-
rich residues, we substituted Val for aGlu45, aGlu175,
and aTrp176, and recorded single-channel currents eli-
cited by ACh. The recordings show profoundly attenuated
channel gating marked by very brief channel openings
flanked by prolonged closings (Fig. 6 c). Furthermore, to
obtain sufficient numbers of channel openings for dwell-
time analysis, we had to increase the ACh concentration
to 1 mM. However, even at this high concentration, the
frequency of openings was so low that clusters of channel
openings were not apparent. Thus, although kinetic fitting
was not possible (Fig. 6 d), substituting the smaller Val
for aGlu45, aGlu175, and aTrp176 profoundly impairs
channel gating, suggesting that the three substituted Val
residues do not provide sufficient steric bulk surrounding
aArg209.DISCUSSION
We examined the functional contributions of residues within
the structural transition zone between the ligand-binding
and pore domains of the muscle-type AChR. The starting
point for this study was the profound attenuation of
agonist-mediated channel gating produced by mutations of
the invariant residue aArg209, together with restoration
of efficient channel gating after charge reversal of both
aArg209 and the nearby aGlu45 (14). Determination of in-
terresidue energetic coupling, based on changes in channel
gating after residue substitutions, revealed strong coupling
between aArg209 and aGlu45. These observations are con-
sistent with the available structural data suggesting that
aArg209 and aGlu45 form a salt bridge within the hydro-
phobic interior of the subunit (10). Other studies, however,
showed that hydrophobic substitutions of aGlu45 had small
effects on agonist-mediated channel gating (14–16),
contrary to expectations based on a single, functionally
crucial salt bridge. Furthermore, the coupling free energy
between aArg209 and aGlu45 was large when examined
in human AChR with ACh as the agonist (14), but was
significantly smaller when examined in mouse AChR with
a combination of ACh and Ch (16). To clarify these issues,
we evaluated whether other nearby electron-rich residues
contribute to channel gating through interaction with
aArg209, compared the coupling free energy between
aArg209 and aGlu45 in human versus mouse AChRs, and
compared the functional consequences of the mutation
aE45R with either ACh or Ch as the agonist.
The coupling free energies presented here are computed
from the channel gating equilibrium constant Q2 obtained
by fitting Scheme 1 to single-channel dwell times obtained
over a range of ACh concentrations. However, Q2 is aBiophysical Journal 104(2) 355–367
FIGURE 5 Kinetics of activation of hydrophobic mutations in the human
AChR Currents elicited by 100 mM ACh are shown at a bandwidth of
10 kHz, with channel openings shown as upward deflections. Histograms
of closed and open dwell times are shown with PDFs computed from global
kinetic fitting overlaid (Table S1).
Biophysical Journal 104(2) 355–367
364 Mukhtasimova and Sinecomposite parameter, which can be understood by expand-
ing Scheme 1 as follows:
ADR%
kD1
k1
ARDA%
kD2
k2
A2R%
pD2
p2
A2R
00
%
b2
a2
A2O
00
Scheme 2
The doubly occupied receptor A2R, rather than leading
directly to the open state, first undergoes a priming step,
defined by the priming rate constants pþ and p, to form
the primed closed state A2R
00 from which the channel opens
(24). In the original primed mechanism, priming occurred in
two separate steps, but Scheme 2 contains only a single
priming step, which is equivalent to the flip step in the initial
work that justified expansion of Scheme 1 (23). Because the
mean duration of the A2R
00 state is briefer than 10 ms, an
instrumentation dead time of 22 ms eliminates most of the
corresponding closed dwell times. Thus Q2, obtained by
fitting Scheme 1 to the data, is given by (P/(1þP))QIntrinsic,
where P ¼ pþ/p and QIntrinsic ¼ b2/a2 (23). As a conse-
quence, an interpretive limitation is that mutations that alter
Q2 may alter the priming step or the gating step, or a combi-
nation of the two.
Analogous reasoning applies in principle to the binding
dissociation constants, K1 and K2, obtained by fitting
Scheme 1 to the data. Like the apparent gating equilibrium
constant, K1 and K2 are apparent dissociation constants with
contributions from both intrinsic binding and priming equi-
librium constants. However, unlike the apparent gating equi-
librium constant, relating the apparent K1 and K2 to the
intrinsic binding and priming equilibrium constants depends
on the sequence of the binding and priming steps, for which
there are several possibilities according to the primed mech-
anism (24). Furthermore, by altering a subset of the rate
constants, a mutant could conceivably alter the sequence
of steps, making comparison problematic. Because gating
is a terminal step immediately preceded by priming, the
issue of the sequence of steps does not arise. Thus, this study
focuses on energetic coupling based on the apparent gating
equilibrium constants.
Recent studies showed that the priming step, or the
equivalent flip step, is strongly agonist dependent, with P
being large for full agonists but small for weak agonists,
whereas the intrinsic channel gating step is similar for
different agonists (23,27). This relationship among P,
QIntrinsic, and the type of agonist may reconcile the differ-
ence in coupling free energies between aArg209 and
aGlu45 for human AChRs activated by ACh versus mouse
AChRs activated by a combination of ACh and Ch. For the
mutant cycle with human AChR, ACh was the agonist for
all four members of the cycle (14), as in Fig. 3, whereas
for the mutant cycle with mouse AChR, Ch was the agonist
for three members and ACh was the agonist for the fourth
member (16). In comparing the two studies, the tacit
assumption was that the relative changes in Q2 produced
a b
c d
FIGURE 6 (a) Single-channel currents elicited
by 100 mM ACh from WT and the triple-Leu-
substituted AChR at a bandwidth 10 kHz. (b)
Histogram of cluster mean open probability (Popen)
shows a broad distribution for the triple mutant
(gray bars), indicating heterogeneous kinetics,
but the distribution is narrow for the WT AChR
(black bars). (c) Single-channel currents elicited
by 1 mM ACh from the triple-Val-substituted
AChR. Clusters could not be identified even at
a concentration of 1 mMACh. (d) Open and closed
time histograms were fitted by sums of exponen-
tials using the program TAC.
Invariant Arginine Couples to Multiple 365by each mutation would be the same for ACh and Ch (16).
However, we found that although the aE45R mutant acti-
vated by ACh showed a decrease in Q2, aE45R activated
by Ch showed an increase. Thus, the functional conse-
quences of the aE45R mutant depend on the type of
agonist. Because the priming step diverges between the
two agonists, and the channel-gating step is agonist inde-
pendent, a favored hypothesis is that the aE45R mutation
affects the priming step differently for the two agonists
but does not affect the intrinsic gating step, giving rise to
agonist dependence of the apparent gating step. Further-
more, the low degree of coupling between aArg209 and
aGlu45 observed in previous studies (16) likely originated
from the agonist-dependent functional consequences of
aE45R.
To our knowledge, this is the first report of an AChR
mutation that alters the apparent channel-gating equilibrium
constant in an agonist-dependent manner. However, AChR
mutations that produce agonist-dependent functional conse-
quences are likely uncommon. A recent study of several
agonists and AChR mutations led to the conclusion that
changes in the channel gating equilibrium constant are
agonist independent (28). In fact, as shown in Tables 1
and 2, channel gating for the double mutation aE45R/
aR209Q approaches that of the WT AChR for both ACh
and Ch. Thus, whether the functional consequences of
a mutation are agonist dependent likely depends on both
the site of the mutation and the substituting residue. The
underlying structural and mechanistic bases of the agonist
dependence remain unclear and call for further studies using
different agonists, sites of substitution, and substituting
residues.Structural determination of the AChR and other recep-
tors from the Cys-loop family shows that aArg209 or the
equivalent residue projects from b-strand 10 into the hydro-
phobic interior of the subunit (10–13,29). The positive
charge on the guanidinium side chain is delocalized across
the three nitrogen atoms, and the hydrocarbon portion of
the side chain increases hydrophobicity. These unique
properties of Arg may explain why it is stable within the
hydrophobic interior of the subunit, and why it is the
only side chain at an equivalent position in all eukaryotic
and the vast majority of prokaryotic Cys-loop receptors.
Residues surrounding aArg209 stem from multiple loops
of the extracellular domain, are chemically compatible
with Arg, and are conserved among all AChR a-subunits.
These residues include aGlu45 from the b1-b2 loop,
aGlu175 and aTrp176 from the b8-b9 loop, and
aAsp138 from the Cys-loop. A high-resolution structure
of a full-length AChR is needed to resolve the question
of whether these electron-rich residues physically associate
with aArg209.
In all four AChR subunits, a central cationic residue sur-
rounded by multiple electron-rich residues is likely present.
In the non-a-subunits, Arg is conserved at positions equiv-
alent to aArg209, and the surrounding electron-rich resi-
dues are also conserved (except in the b-subunit, where
the residue equivalent to aGlu175 is Gln). This raises the
question of what distinguishes the a-subunit from the
non-a-subunits in terms of signal transduction. The central
cationic Arg is crucial in all of the subunits, because muta-
tion of non-a-subunit residues equivalent to aArg209 atten-
uated channel gating to an extent similar to that observed
for aR209Q (30). However, the surrounding electron-richBiophysical Journal 104(2) 355–367
366 Mukhtasimova and Sineresidues appear to be most important in the a-subunit,
although not all residues have been examined. Mutations
of residues near aArg209, aGlu45, aVal46, aSer269, and
aPro272 produced large changes in channel gating,
whereas mutations of equivalent residues in the non-a-sub-
units produced smaller or no changes (14). The subunit-
selective contributions of these residues near aArg209
may be a consequence of the structural specialization of
the a-subunits for agonist recognition. Thus, by virtue of
forming the principal face of the AChR ligand-binding
site, the a-subunit is the most decisive subunit in the trans-
duction of agonist binding into rapid and efficient channel
gating.
Our findings reveal multiple interresidue interactions
between aArg209 and chemically compatible residues in
the same region. Charge reversal of a second anionic re-
sidue, aGlu175, sharply reduces channel gating efficiency,
and mutant cycle analyses show strong coupling between
aGlu175 and aArg209. Furthermore, charge reversal of
both aGlu45 and aGlu175 relieves suppression of channel
gating caused by the mutation aR209Q, and mutant cycle
analysis shows that aGlu45, aGlu175, and aArg209
contribute to channel gating interdependently. The interresi-
due interactions are not purely electrostatic, however,
because substitution of bulky, hydrophobic residues for
the two anionic residues enables efficient channel gating,
suggesting that additional residues, such as aTrp176,
interact with aArg209. Substituting Leu for aGlu45,
aGlu175, and aTrp176 suppresses channel gating and
produces heterogeneous kinetics, suggesting that the large
Leu side chains compensate in part for loss of the three elec-
tron-rich residues. However, substituting the smaller Val for
aGlu45, aGlu175, and aTrp176 results in barely detectable
channel gating, suggesting that the smaller Val side chains
do not supply enough steric bulk around aArg209. A fourth
candidate partner of aArg209, aAsp138, was not evaluated
because the double mutation aR209E/aD138R showed no
channel activity (our own unpublished observations). The
emerging picture is one in which the invariant aArg209
lodges within the hydrophobic interior of the subunit, where
it is surrounded by multiple residues of sufficient electron
density or size, or both. Residues surrounding aArg209
can vary, however. Among eukaryotic Cys-loop receptor
subunits, the residue equivalent to aGlu45 is usually Glu
but can also be Asp, the residue equivalent to aGlu175 is
usually Glu but can also be Gln, and the residue equivalent
to aTrp176 is always aromatic. However, in prokaryotic
Cys-loop receptors, residues surrounding aArg209 show
greater diversity. The residue equivalent to aGlu45 is
usually Glu but can also be Asp, Ile, Ala, Pro, or Trp; the
residue equivalent to aGlu175 is usually Glu but can also
be Gly, Arg, Ser, or Asn; and the residue equivalent to
aTrp176 is usually aromatic but can also be Thr or Asp
(31). Thus, in the transition from prokaryotic to eukaryotic
Cys-loop receptors, residues surrounding aArg209 becameBiophysical Journal 104(2) 355–367more conserved and electron rich, perhaps to increase the
efficiency of signal transduction to meet physiological
needs.SUPPORTING MATERIAL
Six supplemental figures and one table are available at http://www.biophysj.
org/biophysj/supplemental/ S0006-3495(12)05125-9.
We thank Chris Free for outstanding technical contributions, and
T. Therneau for help with statistical analysis.
This work was supported by National Institutes of Health grant NS31744
to S.M.S.REFERENCES
1. Sine, S. M. 2002. The nicotinic receptor ligand binding domain.
J. Neurobiol. 53:431–446.
2. Taly, A., P. J. Corringer,., J. P. Changeux. 2009. Nicotinic receptors:
allosteric transitions and therapeutic targets in the nervous system. Nat.
Rev. Drug Discov. 8:733–750.
3. Celie, P. H., S. E. van Rossum-Fikkert,., T. K. Sixma. 2004. Nicotine
and carbamylcholine binding to nicotinic acetylcholine receptors as
studied in AChBP crystal structures. Neuron. 41:907–914.
4. Gao, F., N. Bren, ., S. M. Sine. 2005. Agonist-mediated conforma-
tional changes in acetylcholine-binding protein revealed by simulation
and intrinsic tryptophan fluorescence. J. Biol. Chem. 280:8443–8451.
5. Hansen, S. B., G. Sulzenbacher, ., Y. Bourne. 2005. Structures of
Aplysia AChBP complexes with nicotinic agonists and antagonists
reveal distinctive binding interfaces and conformations. EMBO J.
24:3635–3646.
6. Li, S., S. Huang,., L. Chen. 2011. Ligand-binding domain of an a7-
nicotinic receptor chimera and its complex with agonist. Nat. Neurosci.
14:1253–1259.
7. Wang, H. L., R. Toghraee,., S. M. Sine. 2009. Single-channel current
through nicotinic receptor produced by closure of binding site C-loop.
Biophys. J. 96:3582–3590.
8. Mukhtasimova, N., C. Free, and S. M. Sine. 2005. Initial coupling of
binding to gating mediated by conserved residues in the muscle nico-
tinic receptor. J. Gen. Physiol. 126:23–39.
9. Grosman, C., M. Zhou, and A. Auerbach. 2000. Mapping the con-
formational wave of acetylcholine receptor channel gating. Nature.
403:773–776.
10. Unwin, N. 2005. Refined structure of the nicotinic acetylcholine
receptor at 4A resolution. J. Mol. Biol. 346:967–989.
11. Dellisanti, C. D., Y. Yao, ., L. Chen. 2007. Crystal structure of the
extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin
at 1.94 A resolution. Nat. Neurosci. 10:953–962.
12. Bocquet, N., H. Nury,., P. J. Corringer. 2009. X-ray structure of a pen-
tameric ligand-gated ion channel in an apparently open conformation.
Nature. 457:111–114.
13. Hilf, R. J., and R. Dutzler. 2009. Structure of a potentially open state
of a proton-activated pentameric ligand-gated ion channel. Nature.
457:115–118.
14. Lee, W. Y., and S. M. Sine. 2005. Principal pathway coupling agonist
binding to channel gating in nicotinic receptors. Nature. 438:243–247.
15. Lee, W. Y., C. R. Free, and S. M. Sine. 2009. Binding to gating trans-
duction in nicotinic receptors: Cys-loop energetically couples to pre-
M1 and M2-M3 regions. J. Neurosci. 29:3189–3199.
16. Purohit, P., and A. Auerbach. 2007. Acetylcholine receptor gating at
extracellular transmembrane domain interface: the ‘‘pre-M1’’ linker.
J. Gen. Physiol. 130:559–568.
Invariant Arginine Couples to Multiple 36717. Lee, B. S., R. B. Gunn, and R. R. Kopito. 1991. Functional differences
among nonerythroid anion exchangers expressed in a transfected
human cell line. J. Biol. Chem. 266:11448–11454.
18. Ohno, K., H. L. Wang,., A. G. Engel. 1996. Congenital myasthenic
syndrome caused by decreased agonist binding affinity due to a muta-
tion in the acetylcholine receptor ε subunit. Neuron. 17:157–170.
19. Lee, W. Y., and S. M. Sine. 2004. Invariant aspartic Acid in muscle
nicotinic receptor contributes selectively to the kinetics of agonist
binding. J. Gen. Physiol. 124:555–567.
20. Colquhoun, D., and F. Sigworth. 1983. Fitting and statistical analysis of
single channel records. In Single Channel Recording. B. Sakmann and
E. Neher, editors.. Plenum Publishing, New York. 191–264.
21. Qin, F., A. Auerbach, and F. Sachs. 1996. Estimating single-channel
kinetic parameters from idealized patch-clamp data containing missed
events. Biophys. J. 70:264–280.
22. Schreiber, G., and A. R. Fersht. 1995. Energetics of protein-protein
interactions: analysis of the barnase-barstar interface by single muta-
tions and double mutant cycles. J. Mol. Biol. 248:478–486.
23. Lape, R., D. Colquhoun, and L. G. Sivilotti. 2008. On the nature
of partial agonism in the nicotinic receptor superfamily. Nature.
454:722–727.
24. Mukhtasimova, N., W. Y. Lee,., S. M. Sine. 2009. Detection and trap-
ping of intermediate states priming nicotinic receptor channel opening.
Nature. 459:451–454.25. Vaughan, C. K., P. Harryson, ., A. R. Fersht. 2002. A structural
double-mutant cycle: estimating the strength of a buried salt bridge
in barnase. Acta Crystallogr. D Biol. Crystallogr. 58:591–600.
26. Shen, X. M., F. Deymeer,., A. G. Engel. 2006. Slow-channel muta-
tion in acetylcholine receptor alphaM4 domain and its efficient knock-
down. Ann. Neurol. 60:128–136.
27. Lape, R., P. Krashia, ., L. G. Sivilotti. 2009. Agonist and blocking
actions of choline and tetramethylammonium on human muscle acetyl-
choline receptors. J. Physiol. 587:5045–5072.
28. Purohit, P., I. Bruhova, and A. Auerbach. 2012. Sources of energy for
gating by neurotransmitters in acetylcholine receptor channels. Proc.
Natl. Acad. Sci. USA. 109:9384–9389.
29. Hibbs, R. E., and E. Gouaux. 2011. Principles of activation and
permeation in an anion-selective Cys-loop receptor. Nature. 474:
54–60.
30. Bruhova, I., and A. Auerbach. 2010. Subunit symmetry at the extracel-
lular domain-transmembrane domain interface in acetylcholine
receptor channel gating. J. Biol. Chem. 285:38898–38904.
31. Tasneem, A., L. M. Iyer, ., L. Aravind. 2005. Identification of the
prokaryotic ligand-gated ion channels and their implications for the
mechanisms and origins of animal Cys-loop ion channels. Genome
Biol. 6:R4.Biophysical Journal 104(2) 355–367
